Yoshitsugu Horio

Mutations of the Epidermal Growth Factor Receptor Gene Predict Prolonged Survival After Gefitinib Treatment in Patients With Non–Small-Cell Lung Cancer With Postoperative Recurrence

Tetsuya Mitsudomi, Takayuki Kosaka, Hideki Endoh et al. · Journal of Clinical Oncology · 2005 · 958 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Ramucirumab plus erlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer (RELAY): a randomised, double-blind, placebo-controlled, phase 3 trial

Kazuhiko Nakagawa, Edward B. Garon, Takashi Seto et al. · The Lancet Oncology · 2019 · 613 citations · Full text

Medicine, Oncology, Pharmacology +12

<i>LATS2</i> Is a Tumor Suppressor Gene of Malignant Mesothelioma

Hideki Murakami, Tetsuya Mizuno, Tetsuo Taniguchi et al. · Cancer Research · 2011 · 270 citations

Veterinary Medicine, Genetics, Oncology +17

Differential Crizotinib Response Duration Among <i>ALK</i> Fusion Variants in <i>ALK</i>-Positive Non–Small-Cell Lung Cancer

Tatsuya Yoshida, Yuko Oya, Kosuke Tanaka et al. · Journal of Clinical Oncology · 2016 · 257 citations

Medicine, Oncology, Pharmacology +17

Epidermal Growth Factor Receptor Mutations in Small Cell Lung Cancer

Akiko Tatematsu, Junichi Shimizu, Yoshiko Murakami et al. · Clinical Cancer Research · 2008 · 190 citations

Medicine, Genetics, Oncology +16